Ginger L Graham
CIK 1192601 · Executive Advisor · last filed 2025-08-15
Ginger L Graham is an Executive Advisor who has filed 92 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for WBA, was dated Aug 15, 2025. Across all open-market trades the lifetime net is −$2.1M, making them a net seller over the disclosed history. 12 SEC filings were submitted jointly with Walgreens Boots Alliance, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AMLN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
108 WILMOT ROAD
DEERFIELD, IL 60015
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Walgreens Boots Alliance, Inc. (WBA) Delisted | Director | 2,150 | $11.98 | $25.8K | $150.2K | 12 | 2025-08-15 |
| Clovis Oncology, Inc. (CLVS) Delisted | Director | — | $0.08 | — | $0 | 8 | 2021-06-11 |
| GENOMIC HEALTH INC (GHDX) Delisted | Director | 53,304 | — | — | $0 | 49 | 2019-10-03 |
| WALGREEN CO (WAG) Delisted | Director | — | — | — | $0 | 5 | 2014-11-03 |
| AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Director | 139,450 | — | — | -$2.21M | 17 | 2009-04-07 |
Recent Filings
92 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-15 | Walgreens Boots Alliance, Inc. (WBA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-11-05 | Walgreens Boots Alliance, Inc. (WBA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-11-03 | Walgreens Boots Alliance, Inc. (WBA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-11-03 | Walgreens Boots Alliance, Inc. (WBA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-11-03 | Walgreens Boots Alliance, Inc. (WBA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-11 | Clovis Oncology, Inc. (CLVS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-11-02 | Walgreens Boots Alliance, Inc. (WBA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-08 | Clovis Oncology, Inc. (CLVS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-11-14 | — | Disp (D) | −53,304 | $0 | |
| 2019-11-04 | Walgreens Boots Alliance, Inc. (WBA) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.